Interpreting the Old Testamentby Walter Harrelson
- 期刊名称The Journal of Religion
- 作者Review by: Arthur L. Merrill
- 卷第45卷
- 期第2期
- 印刷ISSN0022-4189
- 电子ISSN1549-6538
- 文件大小548.50KB
- 发表时间1965-04
- DOI10.2307/1200146
- 页码160-162
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trialBertrand Coiffier; Evgenii A Osmanov; Xiaonan Hong; Adriana Scheliga; Jiri Mayer; Fritz Offner; Simon Rule; Adriana Teixeira; Jan Walewski; Sven de Vos; Michael Crump; Ofer Shpilberg; Dixie-Lee Esseltine; Eugene Zhu; Christopher Enny; Panteli Theocharous; Helgi van de Velde; Yusri A Elsayed; Pier Luigi Zinzani · 2011
061. Rituximab-Associated Neutropaenia: Safety of Retreatment Rituximab TherapyRheumatology · 2015
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trialPier Luigi Zinzani, Nuriet K Khuageva, Huaqing Wang, Bernardo Garicochea, Jan Walewski, Achiel Van Hoof, Pierre Soubeyran, Dolores Caballero, Rena Buckstein, Dixie-Lee Esseltine, Panteli Theocharous, Christopher Enny, Eugene Zhu, Yusri A Elsayed, Bertrand Coiffier · 2012
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in ColombiaBertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; Gonzalez, L. · Value in Health · 2013
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in MexicoBertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A.; de la Torre, L.; Gonzalez, L. · Value in Health · 2013
Is Rituximab Infusion Getting Easier? (Is it Safe to Give Rituximab Faster?)S. Vieira; D. Monroe · 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimenSteven P. Treon; Christina Hanzis; Robert J. Manning; Leukothea Ioakimidis; Christopher J. Patterson; Zachary R. Hunter; Patricia Sheehy; Barry Turnbull · 2011
Are skin tests to Rituximab a risk marker for Rituximab hypersensivity?Galvis, Jonnathan Acevedo; Solano, Emilio; Zepeda, Cristiana Solorzano; De La Hoz, Belen · Journal of Allergy and Clinical Immunology · 2020
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991